Impact of Frailty on Hippocampal Volume in Patients with Chronic Obstructive Pulmonary Disease.
Shun TakahashiTsunahiko HiranoKasumi YasudaTomohiro DonishiKazuyoshi SugaKeiko DoiKeiji OishiShuichiro OhataYoriyuki MurataYoshikazu YamajiMaki Asami-NoyamaNobutaka EdakuniKazuto MatsunagaPublished in: Biomedicines (2021)
Brain frailty may be related to the pathophysiology of poor clinical outcomes in chronic obstructive pulmonary disease (COPD). This study examines the relationship between hippocampal subfield volumes and frailty and depressive symptoms, and their combined association with quality of life (QOL) in patients with COPD. The study involved 40 patients with COPD. Frailty, depressive symptoms and QOL were assessed using Kihon Checklist (KCL), Hospital Anxiety and Depression Scale (HADS), and World Health Organization Quality of Life Assessment (WHO/QOL-26). Anatomical MRI data were acquired, and volumes of the hippocampal subfields were obtained using FreeSurfer (version 6.0). Statistically, HADS score had significant association with WHO/QOL-26 and KCL scores. KCL scores were significantly associated with volumes of left and right whole hippocampi, presubiculum and subiculum, but HADS score had no significant association with whole hippocampi or hippocampal subfield volumes. Meanwhile, WHO/QOL-26 score was significantly associated with volume of the left CA1. There was a significant association between frailty, depression, and QOL. Hippocampal pathology was related to frailty and, to some extent, with QOL in patients with COPD. Our results suggest the impact of frailty on hippocampal volume and their combined associations with poor QOL in COPD.
Keyphrases
- chronic obstructive pulmonary disease
- depressive symptoms
- community dwelling
- lung function
- cerebral ischemia
- temporal lobe epilepsy
- healthcare
- magnetic resonance imaging
- machine learning
- sleep quality
- subarachnoid hemorrhage
- electronic health record
- magnetic resonance
- air pollution
- multiple sclerosis
- big data
- drug induced
- blood brain barrier
- physical activity
- psychometric properties
- adverse drug